Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy

Published:2017-11-16 Issue:2 Volume:283 Page:110-120
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Chowdhury P. S.¹,Chamoto K.¹,Honjo T.¹^ORCID

Affiliation:

1. Department of Immunology and Genomic Medicine; Graduate School of Medicine; Kyoto University; Kyoto Japan

Funder

Cancer Research and Therapeutic Evolution

Tang Prize Foundation

Grant-in-Aid for Young Scientists

Grant-in-Aid for Challenging Research (Exploratory)

Practical Research for Innovative Cancer Control

Postdoctoral Fellowships for Research in Japan

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12708/fullpdf

Reference108 articles.

1. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death;Ishida;EMBO J,1992

2. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes;Agata;Int Immunol,1996

3. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor;Nishimura;Immunity,1999

4. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice;Nishimura;Science,2001

5. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice;Okazaki;Nat Med,2003

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models;OncoImmunology;2024-06-20

2. The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review;Journal of Cancer Metastasis and Treatment;2024-05-28

3. Regulatory mechanisms of PD-1/PD-L1 in cancers;Molecular Cancer;2024-05-18

4. Enhanced systemic antitumor efficacy of PD‐1/PD‐L1 blockade with immunological response induced by photodynamic therapy;Thoracic Cancer;2024-05-13

5. GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy;BMC Immunology;2024-05-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3